Hi,

I'd appreciate some feedback on a European opportunity that feels a little too good to be true.
So the share is BB Biotech AG a Swiss-based investment company, which principal activity is to invest in companies active in the biotechnology industry.

What I like:

- Great Quality (96), Value (87) & Momentum (92) Ranks
- A £30m Negative Enterprise Value
- Stonking Margins (98%) ???
- Pays a good dividend (3.67%)

I particularly like the rising share price (though it's comes off its recent high and is consolidating around 300 CHF) and increasing EPS estimates.

I appreciate that revenues have reduced after bumper years in 2013 & 2014 and the forward estimates for 2016 are weak.

What am I missing?

Thanks for any insight
Phil

Unlock the rest of this article with a 14 day trial

Unlock with Email
Unlock with Google

Already have an account?
Login here